These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23773402)

  • 1. Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.
    Xu W; Zhang H; Wang F; Wang H
    Diagn Pathol; 2013 Jun; 8():95. PubMed ID: 23773402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies.
    Yu L; Chen J
    Diagn Pathol; 2012 Dec; 7():171. PubMed ID: 23217001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis.
    Li K; Hu Yp; Yang Z; Sun T
    Tumour Biol; 2013 Oct; 34(5):2565-72. PubMed ID: 23649653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk.
    Meng X; Liu Y; Liu B
    Diagn Pathol; 2014 Jun; 9():122. PubMed ID: 24948179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
    Zhang S; Jiang J; Tang W; Liu L
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.
    Teng Z; Wang L; Cai S; Yu P; Wang J; Gong J; Liu Y
    PLoS One; 2013; 8(2):e55332. PubMed ID: 23437053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Xu L; Qin Z; Wang F; Si S; Li L; Lin P; Han X; Cai X; Yang H; Gu Y
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene Ala222Val and susceptibility to ovary cancer: a systematic review and meta-analysis.
    Pan X; Lu Y; Long Y; Yao D
    Tumour Biol; 2014 Mar; 35(3):2133-9. PubMed ID: 24146277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between MTHFR C677T Polymorphism and Congenital Heart Disease.
    Liu PF; Ding B; Zhang JY; Mei XF; Li F; Wu P; Mei CH; Zhou YF; Chen T
    Int Heart J; 2020 May; 61(3):553-561. PubMed ID: 32418960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between MTHFR C677T polymorphism and primary open-angle glaucoma: a meta-analysis.
    Huo Y; Zou H; Lang M; Ji SX; Yin XL; Zheng Z; Liu W; Chen CL; Yuan RD; Ye J
    Gene; 2013 Jan; 512(2):179-84. PubMed ID: 23123730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between MTHFR Ala222Val and Glu429Ala polymorphisms and bladder cancer risk: A meta-analysis of case-control studies.
    Shi R; Zhao Z; Zhou H; Zhou J; Tan W
    Biomed Rep; 2014 May; 2(3):396-403. PubMed ID: 24748982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of MTHFR ala222val polymorphism on open-angle glaucoma: a meta-analysis.
    Zhao R; Yin D; Wang E; Si B
    Ophthalmic Genet; 2015 Mar; 36(1):27-30. PubMed ID: 25317717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
    Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.
    Kouidhi S; Rouissi K; Khedhiri S; Ouerhani S; Cherif M; Benammar-Elgaaied A
    Asian Pac J Cancer Prev; 2011; 12(9):2227-32. PubMed ID: 22296361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of MTHFR rs1801133 (677C>T) and rs180113 (1298A>C) Polymorphisms with Susceptibility to Bladder Cancer: A Systematic Review and Meta-Analysis.
    Farshid S; Alijanpour A; Barahman M; Dastgheib SA; Narimani N; Shirinzadeh-Dastgiri Z; Maleki H; Asadian F; Mazaheri M; Neamatzadeh H
    Asian Pac J Cancer Prev; 2022 May; 23(5):1465-1482. PubMed ID: 35633528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between MTHFR Ala222Val polymorphism and risks of hepatitis and hepatitis-related liver cancer: a meta-analysis.
    Zheng R; Zhao W; Dai D; Li C
    Tumour Biol; 2014 Feb; 35(2):1313-8. PubMed ID: 24155211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of
    Zhong L; Fu Q; Zhou S; Chen L; Peng Q
    BMJ Open; 2018 May; 8(5):e020767. PubMed ID: 29804062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.